Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416713 · ClinicalTrials.gov registry record · NA
Way to Safety Cellphone Blocking
A NA study of Teen Drivers and Motor Vehicle Accident, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 2
- Study locations
NCT02416713: Completed NA study of Teen Drivers and Motor Vehicle Accident, sponsored by Children's Hospital of Philadelphia.
NCT02416713 is a NA study of Teen Drivers and Motor Vehicle Accident that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02416713, a NA study of Teen Drivers and Motor Vehicle Accident, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 2
- Study locations
Study Summary
Research participants will be recruited to take part in a randomized control trial. Participants' cellphone use will be observed during an initial baseline period. Participants will then be randomly assigned to one of four conditions: education only (control), opt-in blocking, opt-out blocking, and opt-out blocking with parental notification.
Primary Outcome
Change in number of phone unlocks per hour of drive time between intervention period (last 3 weeks) vs. baseline period (last 3 weeks)
Conditions Studied
Interventions
- DEVICE Cellcontrol DriveID
- OTHER Education Only
Study Locations (2)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-04-13 |
| Est. Completion | 2017-03-24 |
| Phase | NA |
What the finished NCT02416713 record still lists
NCT02416713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Teen Drivers appearing as the primary indexed condition, and to 2 interventions - of which Cellcontrol DriveID is the first listed.
NCT02416713 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02416713 about?
NCT02416713 is a clinical study titled "Way to Safety Cellphone Blocking". Research participants will be recruited to take part in a randomized control trial. Participants' cellphone use will be observed during an initial baseline period. Participants will then be randomly assigned to one of four conditions: education only (control), opt-in blocking, opt-out blocking, and ...
What is the current status of trial NCT02416713?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-04-13. Estimated completion is 2017-03-24.
What conditions does trial NCT02416713 study?
This clinical trial studies the following conditions: Teen Drivers, Motor Vehicle Accident.
What interventions are being tested in trial NCT02416713?
The interventions under investigation include: Cellcontrol DriveID (DEVICE), Education Only (OTHER).
Who is sponsoring clinical trial NCT02416713?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02416713 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02416713's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI